Transitioning to the 2021 optimal formulary for antiretroviral drugs for children: implementation considerations
16 July 2021
| Policy brief
Overview
Antiretroviral treatment optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment.
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal antiretroviral medicines and dosage forms become available.
Related
New findings from the ODYSSEY trial confirm superiority of dolutegravir-based ART in younger children - news release, 16 July 2021
More information
Global HIV Programme: treatment and care in children and adolescents
Editors
WHO
Number of pages
14
Reference numbers
ISBN: 978-92-4-003137-1